Investors & Media

Investor Kit

Join Our Mailing List

Sign up to receive Email updates from Kamada

Latest News

Kamada Announces Expansion of Pivotal Phase 3 Clinical Trial of Inhaled AAT to Additional Six Clinical Sites Across Europe; and Positive Recommendation by DSMB to Continue the Trial Without Modification
May. 17, 2022